A total of 60% of non-hypermutated tumours harbour mutations in the p53 gene32, 33, and 70% of colorectal carcinomas show loss of heterozygosity in 17p, where p53 gene locus resides34, 35. This evidence concerns the gene TP53 and colorectal carcinoma.